G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/48 (2006.01) G01N 33/74 (2006.01)
Patent
CA 2511649
The present invention relates to a methods and means for diagnosing or risk stratification of co-morbidities, particularly cardiovascular complications in diabetes patients. The invention particularly relates to a method for diagnosing whether a diabetes patient is suffering from a cardiovascular complication or is at risk of suffering from a cardiovascular complication, said method comprising the steps of (a) measuring, preferably in vitro, the level(s) of at least one cardiac hormone or a variant thereof in a sample from the patient, (b) diagnosing the cardiovascular complication or the risk of suffering from cardiovascular complication by comparing the measured level(s) to known level(s) associated with the cardiovascular complication or the risk. The present invention also relates to combining the measurement of markers comprising cardiac hormones, natriuretic peptides, inflammation-associated markers, angiogenesis markers and markers for platelet activation. Preferred markers are brain natriuretic peptides (particularly NT- proBNP), P1GF, and sCD40L.
Hess Georg
Horsch Andrea
Poppe Werner
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Multimarker panel for diabetes type 1 and 2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multimarker panel for diabetes type 1 and 2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multimarker panel for diabetes type 1 and 2 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1819080